During a year when hurricanes and weak pricing were headwinds, the company has plenty to look forward to in 2019.

The poultry processor faced numerous headwinds during the period.

Ruling comes after the company ends use of antibiotics medically important to humans.

A change in the company’s antibiotics program to begin in March.

The company’s stock tumbled 5 percent in premarket trading.